AI to find hidden cancer spread in early lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with non-small cell lung cancer.
- Your cancer is stage 1 (early stage).
- You are 18 years or older.
- You have good physical function (KPS score of 70 or higher).
- You have had surgery or stereotactic radiation to remove or treat the main tumor.
- You agree to return for follow-up visits and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence (AI) to help doctors analyze lung nodules seen on CT scans, with the goal of improving diagnosis and follow-up. It may help people who have a lung nodule that needs monitoring or clarification.
This trial tests whether using AI to help radiologists read lung CT scans can find cancer earlier and lower healthcare costs. You may qualify if you are at risk for lung cancer and have not been screened recently.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This study uses an artificial intelligence (AI) tool to look at your scans and health information to better predict whether lung cancer might spread to the brain and how the disease may progress. It aims to help doctors make more personalized treatment decisions.
This trial tests an artificial intelligence platform that helps doctors predict if lymph nodes in the chest contain cancer during a routine ultrasound procedure. It aims to make staging more accurate for people with suspected or confirmed non-small cell lung cancer.
This trial tests whether artificial intelligence can help doctors plan better treatment for non-small cell lung cancer (NSCLC). A team of specialists will use AI tools alongside their usual approach to see if it improves care and safety.
Hear when a new Artificial Intelligence (AI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.